Vikram Thermo (India) Analysis

dividend

Pros

• Dividends per share have increased over the past 10 years.
• Dividends paid are thoroughly covered by earnings (9.2x coverage).
• Vikram Thermo (India)'s pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).

Cons

• Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
• Vikram Thermo (India)'s dividend is below the markets top 25% of dividend payers in India (3.08%).

health

Pros

• Vikram Thermo (India) is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
• Vikram Thermo (India) is profitable, therefore cash runway is not a concern.
• Vikram Thermo (India) is profitable, therefore cash runway is not a concern.
• Debt is well covered by operating cash flow (51.8%, greater than 20% of total debt).
• Debt is covered by short term assets, assets are 4.9x debt.
• Vikram Thermo (India)'s cash and other short term assets cover its long term commitments.
• Interest payments on debt are well covered by earnings (EBIT is 15.6x coverage).
• Vikram Thermo (India)'s level of debt (14%) compared to net worth is satisfactory (less than 40%).

Cons

• The level of debt compared to net worth has increased over the past 5 years (12.4% vs 14% today).
• High level of physical assets or inventory.

management

Pros

• The average tenure for the Vikram Thermo (India) board of directors is over 10 years, this suggests they are a seasoned and experienced board.
• Dhirajlal's remuneration is about average for companies of similar size in India.
• Dhirajlal's compensation has been consistent with company performance over the past year, both up more than 20%.

Cons

misc

Pros

Cons

• Vikram Thermo (India) is not covered by any analysts.
• Vikram Thermo (India) has significant price volatility in the past 3 months.

past

Pros

• Vikram Thermo (India)'s 1-year earnings growth exceeds its 5-year average (110.7% vs 15.2%)
• Vikram Thermo (India)'s year on year earnings growth rate has been positive over the past 5 years.
• Vikram Thermo (India) used its assets more efficiently than the IN Pharmaceuticals industry average last year based on Return on Assets.
• Vikram Thermo (India) has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
• Vikram Thermo (India)'s earnings growth has exceeded the IN Pharmaceuticals industry average in the past year (110.7% vs 22.7%).

Cons

• Vikram Thermo (India) has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).

value

Pros

• Vikram Thermo (India) is good value based on assets compared to the IN Pharmaceuticals industry average.
• Vikram Thermo (India) is good value based on earnings compared to the IN Pharmaceuticals industry average.
• Vikram Thermo (India) is good value based on earnings compared to the India market.
• 530477 outperformed the Market in India which returned -14.5% over the past year.
• BSE:530477 is up 18.5% outperforming the Pharmaceuticals industry which returned 6.8% over the past month.
• BSE:530477 is up 18.5% outperforming the market in India which returned 8% over the past month.

Cons

• Vikram Thermo (India)'s share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
• Vikram Thermo (India)'s share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
• 530477 underperformed the Pharmaceuticals industry which returned 26.7% over the past year.